Intraperitoneal Ropivacaine Instillation for Postoperative Pain Relief after Laparoscopic Cholecystectomy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Tae Han | - |
dc.contributor.author | Kang, Hyun | - |
dc.contributor.author | Park, Jun Seok | - |
dc.contributor.author | Chang, In Taik | - |
dc.contributor.author | Park, Sun Gyoo | - |
dc.date.available | 2019-05-30T00:56:19Z | - |
dc.date.issued | 2010-08 | - |
dc.identifier.issn | 2233-7903 | - |
dc.identifier.issn | 2288--679 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/22281 | - |
dc.description.abstract | Purpose: A study was designed to assess the effect of intraperitoneal instillation of ropivacaine in larparoscopic cholecystectomy patients using computerized patient controlled anesthesia (PCA). Methods: From January 2009 to June 2009, 40 patients with uncomplicated, symptomatic cholecystitis with cholelithiasis who were referred to Chung-Ang University Medical Center for laparoscopic cholecystectomy were included in the study. Patients in group C (control group) received normal saline 100 ml and those in group I (instillation group) received intraperitoneal instillation of 2 mg/kg of ropivacaine diluted in 100 ml saline at the initiation of pneumoperitoneum. Patients were assessed for pain by blinded investigators at 6 time intervals after surgery; 2 hr, 4 hr, 8 hr, 12 hr, 24 hr, and 48 hr. The frequency at which patients pushed the button of the PCA on bolus requirement (FPB) was assessed by a patient-controlled module on the PCA machine. Results: The mean total fentanyl consumption was lower in group 1 (367.39 +/- 85.88) than in group C (535 +/- 100.29) during the 48 hours (P<0.001). Fentanyl velocity and FPB showed significant difference between the groups (P<0.005). Visual analogue scale (VAS) measured pain scores were significantly lower in group I than in group C at 4 hr (P=0.027), 8 hr (P=0.010), 12 hr (P=0.011). Conclusion: Intraperitoneal instillation of ropivacaine at the beginning of laparoscopic cholecystectomy (LC) combined with normal saline infusion is an effective method for reducing pain after LC. (J. Korean Surg Soc 2010;79:130-136) | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SURGICAL SOCIETY | - |
dc.title | Intraperitoneal Ropivacaine Instillation for Postoperative Pain Relief after Laparoscopic Cholecystectomy | - |
dc.type | Article | - |
dc.identifier.doi | 10.4174/jkss.2010.79.2.130 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN SURGICAL SOCIETY, v.79, no.2, pp 130 - 136 | - |
dc.identifier.kciid | ART001465960 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000281011300008 | - |
dc.identifier.scopusid | 2-s2.0-79960174601 | - |
dc.citation.endPage | 136 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 130 | - |
dc.citation.title | JOURNAL OF THE KOREAN SURGICAL SOCIETY | - |
dc.citation.volume | 79 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Instillation | - |
dc.subject.keywordAuthor | Laparoscopic cholecystectomy | - |
dc.subject.keywordAuthor | Ropivacaine hydrochloride | - |
dc.subject.keywordPlus | NORMAL SALINE INFUSION | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | BUPIVACAINE | - |
dc.subject.keywordPlus | ANALGESIA | - |
dc.subject.keywordPlus | PLACEBO | - |
dc.subject.keywordPlus | INFILTRATION | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.